Fig. 2From: Prostate-specific antigen nadir within 1 year of radiotherapy combined with hormone therapy predicts cancer-specific mortality and biochemical recurrence-free survival in prostate cancer patientsUnivariate analysis assessing the ability of nPSA12 to predict PCSM and CSS.Back to article page